GENSCRIPT USA INC

Federal contract awards won by GENSCRIPT USA INC (UEI KVLBRRAQ6UX1), 2021–2024 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

6
awards
0
expiring in 12 months
2
agencies

How their work has changed

Their work has shifted somewhat over the last two years.

Biggest change: Research and Development in Biotechnology (except Nanobiotechnology) (541714) went from 29% of their contracts to 14%.

Industry (NAICS)2 years beforeLast 2 years
Research and Development in Biotechnology (except Nanobiotechnology) (541714)29%14%
All Other Professional, Scientific, and Technical Services (541990)1%11%
In-Vitro Diagnostic Substance Manufacturing (325413)6%11%
Other Professional Equipment and Supplies Merchant Wholesalers (423490)5%0%
Medical Laboratories (621511)0%4%

Share of their contracts in each industry code: the last 24 months compared with the 24 months before, as of Nov 8, 2026. Shown only for companies with at least 5 contracts in each period.

Category award history

142 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: AKKA & CO. LLC took Department of Agriculture 541714 work from GENSCRIPT USA INC (Oct 30, 2026).

Awards

BPA FOR GENSCRIPT SARS-COV-2 SURROGATE VIRUS NEUTRALIZATION TEST KITS AND THE ASSOCIATED REAGENTS
Department of Agriculture · No current value reported · Aug 16, 2022
SYNTHESIS OF SARS-COV-2 VARIANT GENES IN SUPPORT OF COVID-19
Department of Health and Human Services · $702,500 · Apr 6, 2022
PEPTIDE SYNTHESIS SPANNING ENTIRE TB PROTEOME
Department of Health and Human Services · $1,385,450 · Sep 27, 2021
DETECTION OF MUTATION-REACTIVE T-CELLS IN PATIENTS WITH METASTATIC CANCERS
Department of Health and Human Services · $2,052,000 · Sep 24, 2021
SYNTHESIS OF SARS-COV-2 VARIANT GENES IN SUPPORT OF COVID-19
Department of Health and Human Services · $727,163 · Feb 5, 2021